[{"command":"openDialog","selector":"#drupal-modal","settings":null,"data":"\u003Cdiv id=\u0022republish_modal_form\u0022\u003E\u003Cform class=\u0022modal-form-example-modal-form ecl-form\u0022 data-drupal-selector=\u0022modal-form-example-modal-form\u0022 action=\u0022\/en\/article\/modal\/6009\u0022 method=\u0022post\u0022 id=\u0022modal-form-example-modal-form\u0022 accept-charset=\u0022UTF-8\u0022\u003E\u003Cp\u003EHorizon articles can be republished for free under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.\u003C\/p\u003E\n \u003Cp\u003EYou must give appropriate credit. We ask you to do this by:\u003Cbr \/\u003E\n 1) Using the original journalist\u0027s byline\u003Cbr \/\u003E\n 2) Linking back to our original story\u003Cbr \/\u003E\n 3) Using the following text in the footer: This article was originally published in \u003Ca href=\u0027#\u0027\u003EHorizon, the EU Research and Innovation magazine\u003C\/a\u003E\u003C\/p\u003E\n \u003Cp\u003ESee our full republication guidelines \u003Ca href=\u0027\/horizon-magazine\/republish-our-stories\u0027\u003Ehere\u003C\/a\u003E\u003C\/p\u003E\n \u003Cp\u003EHTML for this article, including the attribution and page view counter, is below:\u003C\/p\u003E\u003Cdiv class=\u0022js-form-item form-item js-form-type-textarea form-item-body-content js-form-item-body-content ecl-form-group ecl-form-group--text-area form-no-label ecl-u-mv-m\u0022\u003E\n \n\u003Cdiv\u003E\n \u003Ctextarea data-drupal-selector=\u0022edit-body-content\u0022 aria-describedby=\u0022edit-body-content--description\u0022 id=\u0022edit-body-content\u0022 name=\u0022body_content\u0022 rows=\u00225\u0022 cols=\u002260\u0022 class=\u0022form-textarea ecl-text-area\u0022\u003E\u003Ch2\u003EDiabetes, hydrogen vehicles among targets at EUR 1 bn launch of EU-industry partnerships\u003C\/h2\u003E\u003Cp\u003EThe calls for proposals, announced at an event in Brussels on 9 July, mark the first instalment of funding that is unlocked through seven partnerships with industry, some of which also include links with Member States, worth in total EUR 22 billion.\u003C\/p\u003E\u003Cp\u003EThe EU funding, which is part of Horizon 2020, the EUR 77 billion research and innovation programme that runs from 2014 to 2020, will be matched by a comparable amount from the businesses and organisations which make up the other members of the partnerships in sectors such as pharmaceuticals, aeronautics and electronics.\u003C\/p\u003E\u003Cp\u003E\u2018Only if the best brains from academia, industry, SMEs, research institutes and other organisations come together can we successfully tackle the huge challenges that we are facing,\u2019 European Commission President Jos\u00e9 Manuel Barroso said\u0026nbsp;at the event, which included top representatives from the European Commission and the European Parliament, the current Italian Presidency of the Council of the European Union, the chief executives of some of the biggest European companies, research representatives and other stakeholders.\u003C\/p\u003E\u003Cp\u003EMost of the seven partnerships launched at the event are known as Joint Technology Initiatives (JTIs). While two of them \u2013 Bio-based Industries and Shift2Rail \u2013 are new, it\u2019s the second phase of the remaining five \u2013 Innovative Medicines Initiative 2,\u0026nbsp;Clean Sky 2, Fuel Cells and Hydrogen 2,\u0026nbsp;Electronic Components and Systems, and Single European Sky ATM Research.\u003C\/p\u003E\u003Cp\u003EThey have already resulted in innovations such as a better way to test drugs for Alzheimer\u2019s disease, low-power microprocessors for use in wearable devices, and improvements to the so-called open rotor jet engines where the rotor blades sit outside the engine case, making them more efficient.\u003Cblockquote class=\u0022tw-text-center tw-text-blue tw-font-bold tw-text-2xl lg:tw-w-1\/2 tw-border-2 tw-border-blue tw-p-12 tw-my-8 lg:tw-m-12 lg:tw--ml-16 tw-float-left\u0022\u003E\n \u003Cspan class=\u0022tw-text-5xl tw-rotate-180\u0022\u003E\u201c\u003C\/span\u003E\n \u003Cp class=\u0022tw-font-serif tw-italic\u0022\u003E\u2018Only if the best brains from academia, industry, SMEs, research institutes and other organisations come together can we successfully tackle the huge challenges that we are facing.\u2019\u003C\/p\u003E\n \u003Cfooter\u003E\n \u003Ccite class=\u0022tw-not-italic tw-font-normal tw-text-sm tw-text-black\u0022\u003EEuropean Commission President Jos\u00e9 Manuel Barroso\u003C\/cite\u003E\n \u003C\/footer\u003E\n\u003C\/blockquote\u003E\n\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E100 hydrogen vehicles\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EThe new calls for projects include getting 100 hydrogen-powered vehicles onto Europe\u2019s roads, improving understanding of Type-1 diabetes, which affects young people, developing treatments for age-related eye problems, and designing more efficient planes.\u003C\/p\u003E\u003Cp\u003E\u2018The first calls for proposals illustrate the kinds of activities that the JTIs will support in our goal of accelerating the deployment of great ideas from the lab into the market, for example large-scale demonstrators, testing and prototyping,\u2019 said M\u00e1ire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science.\u003C\/p\u003E\u003Cp\u003EThe idea behind the JTIs is for joint public and private funding to help kick-start areas where it would be too risky or uneconomical for companies to invest in the initial research. It\u2019s particularly relevant for areas such as hard-to-treat diseases, high-tech electronics and bio-based industries, where technology to turn plant waste into plastics and fuel has yet to be made cost-efficient for companies.\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003EPeder Holk Nielsen, the chief executive of enzymes company Novozymes, said that the Bio-based Industries JTI would help companies find ways of economically scaling-up techniques for collecting and processing agricultural waste and converting it into commercial products.\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003E\u2018I think this JTI, this private-public partnership, really makes a difference in Europe as regards our ability to take the global lead in this area,\u2019 he said during a panel discussion of senior executives involved in the JTIs. \u2018It will allow us to make significant experimentation both as regards the physical chains, collecting this material, as well as the actual processing of that material.\u2019\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003ERoch Doliveux, chief executive of medicines maker UCB, and chairman of the Innovative Medicines Initiative governing board, said: \u0027With Innovative Medicines Initiative 2, Europe reinforces its leading position in research and innovation public-private partnerships, engaging all of our brain power across academia and industry to harness the complexity of new sciences and help European citizens live longer and enjoy healthier lives.\u2019\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003EThe calls for projects or participants launched by these partnerships are open to everyone - companies, SMEs, universities, research organisations and others.\u003C\/span\u003E\u003C\/p\u003E\u003C\/textarea\u003E\n\u003C\/div\u003E\n\n \u003Cdiv id=\u0022edit-body-content--description\u0022 class=\u0022ecl-help-block description\u0022\u003E\n Please copy the above code and embed it onto your website to republish.\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003Cinput autocomplete=\u0022off\u0022 data-drupal-selector=\u0022form-iue5soegrf8m3i8juujizj4qztvrtlgk8cx-eb6gsea\u0022 type=\u0022hidden\u0022 name=\u0022form_build_id\u0022 value=\u0022form-IUE5SOeGRF8m3I8JuuJiZJ4QzTvrtLGk8Cx-EB6gSEA\u0022 \/\u003E\n\u003Cinput data-drupal-selector=\u0022edit-modal-form-example-modal-form\u0022 type=\u0022hidden\u0022 name=\u0022form_id\u0022 value=\u0022modal_form_example_modal_form\u0022 \/\u003E\n\u003C\/form\u003E\n\u003C\/div\u003E","dialogOptions":{"width":"800","modal":true,"title":"Republish this content"}}]